FDG PET can determine breast cancer patients not responding to chemo

01/11/2010 | HealthImaging.com

In an Italian study, 18F-FDG PET scans used to monitor patients with estrogen receptor-positive breast cancer tumors showed that 30% of the participants were unresponsive to preoperative chemotherapy. The standardized uptake value threshold needed to determine pathologic response was 50% after the second cycle of treatment, the researchers said.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Director, Site Quality Management
CareFusion
Minneapolis, MN